NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of PharmaCielo Ltd. (OTC: PCLOF), resulting from allegations that PharmaCielo may have issued materially misleading business information to the investing public.
On March 2, 2020, Hindenburg Research published a report alleging that PharmaCielo was “nothing more than the latest self-enrichment scheme drummed up by its co-founder Anthony Wile, who had been charged by the SEC over allegations of securities fraud, stock promotion and market manipulation in the past.” Hindenburg also visited PharmaCielo’s purported greenhouse facilities in Colombia and found that the site was “nothing more than an empty field covered in weeds.”
On this news, PharmaCielo’s stock price fell $0.4579 per share, or 32.25%, to close at $0.9621 per share on March 2, 2020, injuring investors.
Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by PharmaCielo investors. If you purchased shares of PharmaCielo please visit the firm’s website at http://www.rosenlegal.com/cases-register-1798.html to join the class action. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at email@example.com or firstname.lastname@example.org.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has secured hundreds of millions of dollars for investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.